Draft guideline for the format and content of the clinical data section of a new drug application (NDA)
By: Linda Carter.
Publisher: Centre for Drugs and Biologics, Office of Drug Research and Review (HFN-100), Food and Drug Administration
Published: 1986
Place of publication: Rockville, MD
Language: eng
Number of pages: 102
Notes: Docket no 85D-0467.

Document no USCLIN.

Reprinted by Datapharm Information Services.